These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 324349)
1. [Metabolism of o,p'-DDD (mitotane) in human and animals. Actual notions and practical deductions (author's transl)]. Touitou Y; Bogdan A; Legrand JC; Desgrez P Ann Endocrinol (Paris); 1977; 38(1):13-25. PubMed ID: 324349 [TBL] [Abstract][Full Text] [Related]
2. The lymphocytic absorption of p,p'-DDT and some structurally-related compounds in the rat. Sieber SM Pharmacology; 1976; 14(5):443-54. PubMed ID: 1031215 [TBL] [Abstract][Full Text] [Related]
3. Effects of adrenolytic mitotane on drug elimination pathways assessed in vitro. Theile D; Haefeli WE; Weiss J Endocrine; 2015 Aug; 49(3):842-53. PubMed ID: 25542188 [TBL] [Abstract][Full Text] [Related]
4. Comparative CYP-dependent binding of the adrenocortical toxicants 3-methylsulfonyl-DDE and o,p'-DDD in Y-1 adrenal cells. Hermansson V; Asp V; Bergman A; Bergström U; Brandt I Arch Toxicol; 2007 Nov; 81(11):793-801. PubMed ID: 17487473 [TBL] [Abstract][Full Text] [Related]
5. Clinical role of determination of plasma mitotane and its metabolites levels in patients with adrenal cancer: results of a long-term follow-up. Kasperlik-Zaluska AA; Cichocki A J Exp Ther Oncol; 2005; 5(2):125-32. PubMed ID: 16471038 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of the adrenocorticolytic compounds 3-methylsulphonyl-DDE and o,p'-DDD (mitotane) in Minipigs. Hermansson V; Cantillana T; Hovander L; Bergman A; Ljungvall K; Magnusson U; Törneke K; Brandt I Cancer Chemother Pharmacol; 2008 Feb; 61(2):267-74. PubMed ID: 17431626 [TBL] [Abstract][Full Text] [Related]
7. Cytochrome P450-catalyzed binding of 3-methylsulfonyl-DDE and o,p'-DDD in human adrenal zona fasciculata/reticularis. Lindhe O; Skogseid B; Brandt I J Clin Endocrinol Metab; 2002 Mar; 87(3):1319-26. PubMed ID: 11889204 [TBL] [Abstract][Full Text] [Related]
8. Metabolism of 1-(0-chlorophenyl)-1-(p-chlorophenyl)-2,2-dichloroethane (o,p'-DDD) in rats. Reif VD; Sinsheimer JE Drug Metab Dispos; 1975; 3(1):15-25. PubMed ID: 234830 [TBL] [Abstract][Full Text] [Related]
9. Anaerobic biodegradation of DDT residues (DDT, DDD, and DDE) in estuarine sediment. Huang HJ; Liu SM; Kuo CE J Environ Sci Health B; 2001 May; 36(3):273-88. PubMed ID: 11411851 [TBL] [Abstract][Full Text] [Related]
10. Occurrences and fate of DDT principal isomers/metabolites, DDA, and o,p'-DDD enantiomers in fish, sediment and water at a DDT-impacted Superfund site. Garrison AW; Cyterski M; Roberts KD; Burdette D; Williamson J; Avants JK Environ Pollut; 2014 Nov; 194():224-234. PubMed ID: 25150505 [TBL] [Abstract][Full Text] [Related]
11. Association of mitotane with chylomicrons and serum lipoproteins: practical implications for treatment of adrenocortical carcinoma. Kroiss M; Plonné D; Kendl S; Schirmer D; Ronchi CL; Schirbel A; Zink M; Lapa C; Klinker H; Fassnacht M; Heinz W; Sbiera S Eur J Endocrinol; 2016 Mar; 174(3):343-53. PubMed ID: 26671975 [TBL] [Abstract][Full Text] [Related]
12. Bovine adrenal cortex transformations of mitotane [1-(2-chlorophenyl)-1-(4-chlorophenyl)-2,2-dichloroethane; o,p'-DDD] and its p,p'- and m,p'-isomers. Cai W; Benitez R; Counsell RE; Djanegara T; Schteingart DE; Sinsheimer JE; Wotring LL Biochem Pharmacol; 1995 May; 49(10):1483-9. PubMed ID: 7763292 [TBL] [Abstract][Full Text] [Related]
13. DDT- and DDE-induced disruption of ovarian steroidogenesis in prepubertal porcine ovarian follicles: a possible interaction with the main steroidogenic enzymes and estrogen receptor beta. Wójtowicz AK; Kajta M; Gregoraszczuk EŁ J Physiol Pharmacol; 2007 Dec; 58(4):873-85. PubMed ID: 18195494 [TBL] [Abstract][Full Text] [Related]
14. o,p'-DDD (mitotane) treatment for Cushing's syndrome: adrenal drug concentration and inhibition in vitro of steroid synthesis. Touitou Y; Moolenaar AJ; Bogdan A; Auzéby A; Luton JP Eur J Clin Pharmacol; 1985; 29(4):483-7. PubMed ID: 4092727 [TBL] [Abstract][Full Text] [Related]
15. A simple HPLC method for plasma level monitoring of mitotane and its two main metabolites in adrenocortical cancer patients. Garg MB; Sakoff JA; Ackland SP J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Aug; 879(23):2201-5. PubMed ID: 21719363 [TBL] [Abstract][Full Text] [Related]
16. Two-dimensional chromatography for enantiomeric analysis of mitotane and its metabolite o,p'-DDA in patients with adrenocortical carcinoma indicates enantioselective metabolism. Stadler G; de Almeida Veiga A; Rita Corso C; Bach de Assis C; de Toledo Nogueira B; Regina Rocha Martins L; Cruz Bonk B; Lada Degaut Pontes F; Cavalcante de Figueiredo B; Mera de Souza L Bioorg Chem; 2023 Dec; 141():106835. PubMed ID: 37713949 [TBL] [Abstract][Full Text] [Related]
17. Plasma level monitoring of mitotane (o,p'-DDD) and its metabolite (o,p'-DDE) during long-term treatment of Cushing's disease with low doses. Benecke R; Keller E; Vetter B; de Zeeuw RA Eur J Clin Pharmacol; 1991; 41(3):259-61. PubMed ID: 1748144 [TBL] [Abstract][Full Text] [Related]
18. [Levels of dichlorodiphenyltrichloroethane internal exposure levels in pregnant women of Xiamen and influencing factors]. Yu XS; He J; Chen JH; Lai ZB; Su YH; Shi MM; Huang ZX; Cheng QJ; Ke XY; Zhao BH Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Nov; 50(11):982-989. PubMed ID: 27903362 [No Abstract] [Full Text] [Related]
19. A high-pressure liquid chromatographic method for measuring mitotane [1,1-(o,p'-Dichlorodiphenyl)-2,2-dichloroethane] and its metabolite 1,1-(o,p'-Dichlorodiphenyl)-2,2-dichloroethene in plasma. Andersen A; Warren DJ; Nome O; Vesterhus L; Slørdal L Ther Drug Monit; 1995 Oct; 17(5):526-31. PubMed ID: 8585118 [TBL] [Abstract][Full Text] [Related]
20. Determination of mitotane (o,p-DDD) and its metabolites o,p-DDA and o,p-DDE in plasma by high-performance liquid chromatography. Andersen A; Kasperlik-Zaluska AA; Warren DJ Ther Drug Monit; 1999 Jun; 21(3):355-9. PubMed ID: 10365653 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]